Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 30 April 2024.Powered by Capital Market - Live News

Net profit of Vivanza Biosciences declined 54.35% to Rs 0.21 crore in the quarter ended December 2023 as against Rs 0.46 crore during the previous quarter ended December 2022. Sales rose 11.95% to Rs 6.56 crore in the quarter ended December 2023 as against Rs 5.86 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales6.565.86 12 OPM %4.429.56 - PBDT0.210.46 -54 PBT0.210.46 -54 NP0.210.46 -54 Powered by Capital Market - Live News

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 6 February 2024. The meeting would commence at 3.30 pm.Powered by Capital Market - Live News

Net profit of Vivanza Biosciences rose 52.94% to Rs 0.26 crore in the quarter ended September 2023 as against Rs 0.17 crore during the previous quarter ended September 2022. Sales rose 464.44% to Rs 7.62 crore in the quarter ended September 2023 as against Rs 1.35 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales7.621.35 464 OPM %4.20-2.22 - PBDT0.260.16 63 PBT0.260.16 63 NP0.260.17 53 Powered by Capital Market - Live News

Net profit of Vivanza Biosciences rose 26.67% to Rs 0.19 crore in the quarter ended September 2023 as against Rs 0.15 crore during the previous quarter ended September 2022. Sales rose 272.12% to Rs 3.87 crore in the quarter ended September 2023 as against Rs 1.04 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales3.871.04 272 OPM %6.460.96 - PBDT0.190.15 27 PBT0.190.15 27 NP0.190.15 27 Powered by Capital Market - Live News